Novartis launches first large-scale research study in multiple sclerosis that allows participants to contribute from smartphones
EAST HANOVER, N.J., Aug. 21, 2017 /PRNewswire/ — Novartis announced today the launch of a mobile research study for people with multiple sclerosis (MS) that collects data via their smartphone, without the need for clinic visits. The study, Evaluation of Evidence from Smart Phone Sensors and Patient-Reported Outcomes in Participants with Multiple Sclerosis (elevateMS), is designed to collect sensor-based data from physical tasks and symptoms. It aims to improve understanding of the daily challenges patients with MS can have and to uncover new potential measurements of treatment effectiveness through real-time data collection from participants in their everyday life.
The elevateMS study, which was developed in partnership with Sage Bionetworks, uses a mobile application that was built on the Apple ResearchKit®* platform. This emerging digital smartphone research platform allows study participants to contribute to research from home or on the go. At the same time, it enables researchers to collect data in the participant’s everyday environment. To download the app and enroll in the study, please visit https://itunes.apple.com/us/app/elevatems/id1233909485?ls=1&mt=8.
The mobile app was designed with input from patients, neurologists and advocates. Patients commented on the app’s user interface, what the study should measure, and how the app should track patient activity and disease symptoms. Read the full story.